Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01776151 · ClinicalTrials.gov registry record
Arterial Elasticity: A Substudy of Strategic Timing of AntiRetroviral Treatment (START)
A clinical trial, sponsored by University of Minnesota.
- Completed
- Registry status
- 337
- Enrollment target
NCT01776151 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 337 participants.
The verdict
NCT01776151 has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 337 participants
- Enrollment target
Study Summary
The purpose of this study is to find out if starting anti-retroviral therapy (ART) above 500 cluster-of-differentiation-4 (CD4)+ cells/milliliter (mL) ('early ART group') is better at reducing the stiffness of arteries than waiting to start ART until the CD4+ drops below 350 cells/mL ('deferred ART group'). Artery stiffness has been associated with an increased risk of cardiovascular (heart) disease, and could be useful as an earlier indicator of heart disease. In this study, the stiffness of arteries will be measured at study entry, months 4, 8, 12, and annually thereafter, using a tonometer on the participant's forearm.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 337 participants |
| Start Date | 2009-04-15 |
| Est. Completion | 2015-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01776151
The ClinicalTrials.gov registry entry for NCT01776151 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 337 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01776151 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01776151 about?
NCT01776151 is a clinical study titled "Arterial Elasticity: A Substudy of Strategic Timing of AntiRetroviral Treatment (START)". The purpose of this study is to find out if starting anti-retroviral therapy (ART) above 500 cluster-of-differentiation-4 (CD4)+ cells/milliliter (mL) ('early ART group') is better at reducing the stiffness of arteries than waiting to start ART until the CD4+ drops below 350 cells/mL ('deferred ART ...
What is the current status of trial NCT01776151?
This trial is currently completed. The enrollment target is 337 participants. The study started on 2009-04-15. Estimated completion is 2015-09.
Who is sponsoring clinical trial NCT01776151?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.